Abstract
1. Degeneration of nigrostriatal dopaminergic neurons is the major pathogenic substrate of Parkinson's disease (PD). It is assumed that the lethal trigger is the accumulation of oxidative reactive species generated during metabolism of the natural neurotransmitter dopamine.
2. We have recently shown that dopamine is capable of inducing programmed cell death (PCD) or apoptosis in cultured postmitotic chick sympathetic neurons and rat PC12 pheochromocytoma cells.
3. The bcl-2 gene encodes a protein which blocks physiological PCD in many mammalian cells. In an attempt to elucidate further the mechanism of dopamine toxicity, we examined the potential protective effect of bcl-2 in PC12 cells which were transfected with the protooncogene.
4. In our experiments, Bcl-2 producing cells showed a marked resistance to dopamine toxicity. The percentage of nuclear condensation and DNA fragmentation visualized by the end-labeling method following dopamine treatment was significantly lower in bcl-2 expressing cells. Bcl-2 did not protect PC12 cells against toxicity induced by exposure to dopamine-melanin. Extracts of PC12 cells containing Bcl-2 inhibited dopamine autooxidation and formation of dopamine-melanin. Furthermore, the presence of Bcl-2 protected cells from thiol imbalance and prevented thiol loss following exposure to dopamine.
5. The protective effects of Bcl-2 against dopamine toxicity may be explained, in part, by its action as an antioxidant and by its interference in the production of toxic agents. The possible protection by Bcl-2 against neuronal degeneration caused by dopamine may play a role in the pathogenesis of PD andmay provide a new direction for the development of neuroprotective therapies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Agid, Y. (1995). Aging, disease and nerve cell death. Bull. Acad. Natl. Med. 179:1193–1203.
Allsopp, T. E., Wyatt, S., Paterson, F. H., and Davies, A. M. (1993). The proto-oncogene Bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295–307.
Anderson, S., Davies, D. N., and Bahlback, H. (1989). Cloning structure and expression of the mitochondrial cytochrome p-450 sterol 6-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222–8229.
Bindoli, A., Rigobello, M. P., and Deeble, D. J. (1992). Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radical Biol. Med. 13:391–405.
Cohen, G. (1983). The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence. J. Neural. Transm. Suppl.:89–103.
Damier, P. D., Zhang, H. P., Agid, Y., and Javoy-Agid, F. (1993). Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52:1–6.
Das, K. C., Abramson, M. B., and Katzman, R. (1978). Neuronal pigments: Spectroscopic characterization of human brain melanin. J. Neurochem. 30:601–605.
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C. D. (1989). Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381–389.
Garcia, I., Martinou, I., Tsujimoto, Y., and Martinou, J. (1992). Preventing of programmed cell death of sympathetic neurons by the Bcl-2 proto-oncogene. Science 258:302–304.
Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493–500.
Graham, D. G. (1978). Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:633–643.
Hockenbery, D., Zuttern, B., Hickey, W., Nahm, M., and Korsmeyer, S. J. (19991). BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88:6961–6965.
Hockenbery, D., Oltvai, Z. N., Yin, X., Milliman, C. L., and Korsmeyer, S. J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251.
Jacobson, M. D., and Raff, M. (1995). Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814–816.
Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, S. J., Ord, T., and Bredesen, E. (1993). Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274–1277.
Korsmeyer, S. J., Shutter, J. R., Veis, D. J., Merry, D. E., and Oltvai, Z. N. (1993). Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4(6):327–332.
Korsmeyer, S. J., Yin, X. M., Oltvai, Z. N., Veis-Novack, D. J., and Linette, G. P. (1995). Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim. Biophys. Acta 1271(1):63–66.
Krajewski, S., Tanaka, S., Takayama, S., Schibler, M. J., Fenton, W., and Reede, J. C. (1993). Investigation of the subcellular distribution of the bcl-2 oncoprotein: Mitochondrial membranes. Cancer Res. 53(19):4701–4714.
Lin, K. I., Lee, S. H., Narayanan, R., Baraban, J. M., Hardwick, J. M., and Ratan, R. R. (1995). Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell Biol. 131(5):1149–1161.
Lindenboim, L., Diamond, R., Rothenberg, E., and Stein, R. (1995). Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Res. 55:1242–1247.
Mah, S. P., Zhong, L. T., Liu, A., Roghani, R. H., Edwards, R. H., and Bredesen, D. E. (1993). The proto-oncogene Bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60:1183–1186.
Merry, D. E., Veis, D. J., Hickey, W. F., and Korsmeyer, S. J. (1994). Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120(2):301–311.
Michel, P. P., and Hefti, F. (1990). Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26(4):428–435.
Nunez, G., and Clarke, M. F. (1994). The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol. 4:399–403.
Offen, D., Ziv, I., Gorodin, S., Malik, Z., Barzilai, A., and Melamed, E. (1995). Dopamine-induced programmed cell death in mouse thymocytes. Biochim. Biophys. Acta 1268:171–177.
Olanow, C. W. (1992). An introduction to the free radical hypothesis in Parkinson's idsease. Ann. Neurol. 32:S2–S9.
Prota, G. (1980). Recent advances in the chemistry of melanogenesis in mammals. J. Invest. Dermatol. 75:122–127.
Reed, J. C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1–6.
Rice Ivens, C. A., Diplock, A. T., and Synons, N. C. R. (1991). Detection and quantitation of thiol groups in proteins and non-protein. Techniq. Free Radical Res. 22:229.
Sarafian, T. A., Vartavarian, L., Dane, D. J., Bredesen, D. E., and Verity, M. A. (1994). Bcl-2 expression decreases methyl mercury-induced free radical generation and cell killing in neural cell line. Toxicol. Lett. 74(2):149–155.
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., and Tsujimoto, Y. (1995). Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374:811–813.
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, p., and Marsden, D. (1994). Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:348–355.
Sotomatsu, M., Ganaka, M., and Hirai, S. (1994). Synthetic melanin and ferric ions promote superoxide anion-mediated lipid peroxidation. FEBS Lett. 342:105–118.
Steinman, H. M. (1995). The Bcl-2 oncoprotein function as a pro-oxidant. Biol. Chem. 270(8):3487–3490.
Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J. (1993). Bcl-2 deficient mice demonstrate lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229–240.
Zhong, L., Sarafian, T., Kane, D. J., Charles, A. C., Mah, S. P., Edwards, R. H., and Bredesen, D. E. (1993). Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90:4533–4537.
Ziv, I., Melamed, E., Nardi, N., Luria, D., Achiron, A., Offen, D., and Barzilai, A. (1994). Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel pathogenic mechanism in Parkinson's disease. Neurosci. Lett. 170:136–140.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Offen, D., Ziv, I., Panet, H. et al. Dopamine-Induced Apoptosis Is Inhibited in PC12 Cells Expressing Bcl-2. Cell Mol Neurobiol 17, 289–304 (1997). https://doi.org/10.1023/A:1026390201168
Issue Date:
DOI: https://doi.org/10.1023/A:1026390201168